KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that five abstracts, including one late-breaking submission, have been accepted for presentation at the 2026 Global Angioedema Leadership ...
Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology ...
Creating professional presentations can take lots of time. With Adobe Acrobat Studio’s new AI tools, you can do it in minutes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results